PL1912513T3 - Nowe frakcje białek mleka i ich zastosowanie do zapobiegania lub leczenia przewlekłych chorób zapalnych - Google Patents

Nowe frakcje białek mleka i ich zastosowanie do zapobiegania lub leczenia przewlekłych chorób zapalnych

Info

Publication number
PL1912513T3
PL1912513T3 PL06794209T PL06794209T PL1912513T3 PL 1912513 T3 PL1912513 T3 PL 1912513T3 PL 06794209 T PL06794209 T PL 06794209T PL 06794209 T PL06794209 T PL 06794209T PL 1912513 T3 PL1912513 T3 PL 1912513T3
Authority
PL
Poland
Prior art keywords
preventing
inflammatory diseases
chronic inflammatory
milk protein
treating chronic
Prior art date
Application number
PL06794209T
Other languages
English (en)
Inventor
Takashi Mikogami
Jérôme SOUPPE
Pierre Jouan
Michel Bourtourault
Original Assignee
Cie Laitiere Europeenne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cie Laitiere Europeenne filed Critical Cie Laitiere Europeenne
Publication of PL1912513T3 publication Critical patent/PL1912513T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/14Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/146Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06794209T 2005-07-29 2006-07-25 Nowe frakcje białek mleka i ich zastosowanie do zapobiegania lub leczenia przewlekłych chorób zapalnych PL1912513T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0508177A FR2889068B1 (fr) 2005-07-29 2005-07-29 Nouvelles fractions proteiques laitieres et leur utilisation pour la prevention ou le traitement des maladies inflammatoires chroniques
PCT/FR2006/001810 WO2007012748A2 (fr) 2005-07-29 2006-07-25 Nouvelles fractions proteiques laitieres et leur utilisation pour la prevention ou le traitement des maladies inflammatoires chroniques
EP06794209.4A EP1912513B1 (fr) 2005-07-29 2006-07-25 Nouvelles fractions proteiques laitieres et leur utilisation pour la prevention ou le traitement des maladies inflammatoires chroniques

Publications (1)

Publication Number Publication Date
PL1912513T3 true PL1912513T3 (pl) 2014-03-31

Family

ID=36177877

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06794209T PL1912513T3 (pl) 2005-07-29 2006-07-25 Nowe frakcje białek mleka i ich zastosowanie do zapobiegania lub leczenia przewlekłych chorób zapalnych

Country Status (16)

Country Link
US (1) US7982001B2 (pl)
EP (1) EP1912513B1 (pl)
JP (1) JP5709353B2 (pl)
KR (1) KR101404035B1 (pl)
CN (1) CN101272694B (pl)
AU (1) AU2006273912B2 (pl)
CA (1) CA2616345C (pl)
CY (1) CY1114811T1 (pl)
DK (1) DK1912513T3 (pl)
ES (1) ES2438591T3 (pl)
FR (1) FR2889068B1 (pl)
NZ (1) NZ565287A (pl)
PL (1) PL1912513T3 (pl)
PT (1) PT1912513E (pl)
SI (1) SI1912513T1 (pl)
WO (1) WO2007012748A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827290B1 (fr) 2001-07-13 2004-07-09 Pierre Jouan Biotechnologies Sa Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques
JP2008189637A (ja) * 2007-02-08 2008-08-21 Snow Brand Milk Prod Co Ltd 自己免疫疾患予防剤
CA2696145C (en) * 2007-07-10 2016-12-20 Glanbia Nutritionals Method for removing endotoxin from proteins
NZ589311A (en) * 2008-05-14 2012-08-31 Agriculture Victoria Serv Pty Angiogenin-enriched milk fractions prepared by methods involving heating the milk to over 70 degrees celsius for at least one minute
US11109604B2 (en) 2019-05-09 2021-09-07 Memtec LLC Dairy processing systems and methods
FR3115037B1 (fr) 2020-10-12 2025-02-21 Cie Laitiere Europeenne Procédé de purification de fraction de protéines cationiques et fraction ainsi obtenue
FR3159096A1 (fr) 2024-02-08 2025-08-15 Compagnie Laitiere Europeenne Utilisation de TGF-β pour la prévention et le traitement des manifestations névralgiques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458818B (sv) * 1987-11-27 1989-05-16 Svenska Mejeriernas Riksforeni Foerfarande foer utvinning av rena fraktioner av laktoperoxidas och laktoferrin ur mjoelkserum
US7033610B2 (en) * 1990-07-13 2006-04-25 Gropep Pty, Ltd. Growth-promoting agent
DK0545946T3 (da) * 1990-07-13 2005-05-23 Gropep Ltd Vækstfremmende middel
DE69925870T2 (de) * 1999-10-06 2005-12-08 Campina B.V. Verfahren zur bereitstellung von wachstumsfaktozubereitungen (tgf-beta und igf-1) mit niedriger gegenseitiger verunreinigung aus milchprodukten
CN1555384B (zh) * 2001-07-20 2010-05-26 坎皮纳公司 从乳制品获得具有低相互交叉污染的生长因子(TGF-β和IGF-1)、乳过氧化物酶和免疫球蛋白制剂的方法
FR2841747B1 (fr) * 2002-07-02 2004-08-20 Cie Laitiere Europeenne Isolat de proteines de lait et procede pour sa preparation
CN1557482A (zh) * 2004-02-04 2004-12-29 高春平 调节免疫功能、抗肿瘤的天然营养剂
US20050208638A1 (en) * 2004-03-22 2005-09-22 Chao Wu Process for preparing bioactive protein-enriched whey products

Also Published As

Publication number Publication date
WO2007012748A2 (fr) 2007-02-01
WO2007012748A3 (fr) 2007-06-07
FR2889068A1 (fr) 2007-02-02
EP1912513A2 (fr) 2008-04-23
SI1912513T1 (sl) 2014-01-31
CN101272694B (zh) 2012-04-18
ES2438591T3 (es) 2014-01-17
JP5709353B2 (ja) 2015-04-30
PT1912513E (pt) 2013-12-17
JP2009502892A (ja) 2009-01-29
US7982001B2 (en) 2011-07-19
NZ565287A (en) 2010-12-24
FR2889068B1 (fr) 2012-03-02
CY1114811T1 (el) 2016-12-14
DK1912513T3 (da) 2014-01-06
CN101272694A (zh) 2008-09-24
CA2616345A1 (fr) 2007-02-01
EP1912513B1 (fr) 2013-09-11
CA2616345C (fr) 2014-05-06
US20080207531A1 (en) 2008-08-28
KR101404035B1 (ko) 2014-06-19
AU2006273912B2 (en) 2013-01-24
KR20080048456A (ko) 2008-06-02
AU2006273912A1 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
IL185547A0 (en) Lipocalin protein
IL187703A0 (en) Treatment of protein folding disorders
IL199045A0 (en) Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
PT2592072T (pt) Inibidores de proteína tirosina fosfatase humana e sua utilização
ZA200804742B (en) Compounds for the treatment of inflammatory disorders and microbial diseases
IL191637A0 (en) Compounds for the treatment of inflammatory disorders and microbial diseases
GB0818413D0 (en) CD47 Related compositions and methods for treating immunological diseases and disorders
ZA200902419B (en) Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
EP1960523A4 (en) MODIFIED POREN FORMING PROTEIN TOXINS AND USE THEREOF
EP1922086A4 (en) TARGETED PROTEIN KINASE C HEMMER AND ITS USES
GB0422901D0 (en) Lipocalin protein
SI1912513T1 (sl) Nove mlečne proteinske frakcije in njihova uporaba za preprečevanje ali zdravljenje kroničnih vnetnih bolezni
GB0514482D0 (en) Protein
GB0516058D0 (en) New protein isoforms and uses thereof
EP1805210A4 (en) NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
BRPI0714307A2 (pt) Uso de benzamidas trifluormetil-substituídas no tratamento de distúrbios neurológicos
EP1969008A4 (en) ANTIBODIES TO INTERLEUKIN-22 BINDING PROTEIN AND ITS APPLICATIONS IN THE TREATMENT OF METABOLISM DISORDERS
ZA200904382B (en) Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-retaled diseases
EP1865952A4 (en) COMPOSITIONS CONTAINING HISTAMINES FOR THE TREATMENT OF ALLERGIES
EP1922328A4 (en) PEPTIDES TARGETED ON C PROTEIN KINASE ISOFORMS AND USE THEREOF
EP1877427A4 (en) NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
GB0522667D0 (en) New protein isoforms and uses thereof
IL198079A0 (en) Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
GB0614911D0 (en) New protein isoforms and uses thereof
IL165429A0 (en) CD16A binding proteins and use for the treatment of immune disorders